Pharmafile Logo

Gilead opens new research centre bringing together oncology, inflammation and research data science teams

The centre in California supports the company’s $32bn US investment
- PMLiVE

Gilead Sciences has opened its 182,000-square-foot Research Center at its Foster City, California headquarters, expanding capabilities in oncology, inflammation and research data science to advance medicines for some of the world’s most challenging diseases.

The company currently employs approximately 11,000 people across the US, including more than 7,400 in California and nearly 4,700 in the San FranciscoBay Area. The centre marks the latest milestone in the company’s $32bn investment in US research, development and manufacturing up until 2030

Gilead marked the milestone with a ribbon-cutting ceremony attended by company leaders, scientists and government and community guests.

Daniel O’Day, Chairman and CEO of Gilead Sciences, said: “We are in a moment of unprecedented opportunity in science and technology. Our new Research Center will help Gilead scientists make the most of that opportunity, delivering more breakthrough medicines faster.”

Designed with input from Gilead research colleagues, the five-story centre will support approximately 325 employees, including 260 laboratory scientists. Flexible laboratory neighbourhoods, specialised collaboration spaces and shared technology platforms will enable teams to adapt as scientific needs evolve. All-electric systems, energy-efficient design and water-saving landscaping featuring California native plants are expected to support LEED Gold certification.

A dedicated bridge to an adjacent building streamlines the transfer of equipment and research materials, while the new Research Quad provides a central gathering space for collaboration and scientific exchange.

“The future of biomedical innovation depends on bringing together exceptional science, advanced technologies and diverse expertise,” said Flavius Martin, Executive Vice President, Research of Gilead Sciences. “This centre was designed to do exactly that. By co-locating key research disciplines and expanding our data science capabilities, we are strengthening the infrastructure needed to accelerate discovery and advance meaningful innovations.”

The centre is one of three major Foster City projects. The other two projects include the Technical Development Center, expected to open in 2027, and the biologics facility, which broke ground in August and is expected to open in 2029.

PMGroup
9th September 2026
Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links